A new daily pill for obesity, orforglipron, has shown promising results in a major clinical trial, helping patients lose ...

Eli Lilly and Company (NYSE:LLY) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Eli Lilly and Company ...

Peter Kyle said he wants the likes of Wegovy and Mounjaro to be 'widely used' and made 'available to everyone from every ...

Amy Schumer has undergone back surgery. The Life and Beth actress - who has six-year-old son Gene with husband Chris Fischer ...

Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

Scientists are looking into alternative weight loss solutions beyond GLP-1 medications like Mounjaro, Ozempic and Wegovy ...

A woman who lost 23 stone while on Mounjaro has revealed the frustrating side effect she still has to deal with. Weight loss drugs have become extremely popular in the last year or so, with ...

This will be the first time the option has been taken up since it was introduced at the beginning of 2025, under the Medical ...

A study found jabs were linked to a 'modestly increased risk' of diabetic retinopathy-a condition caused by damage to blood ...

Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 medications.

Eli Lilly’s GIP/GLP-1 dual receptor agonist Mounjaro (tirzepatide) has demonstrated cardiovascular protection in a late-stage ...